Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates various biological processes, including proliferation, metastasis, angiogenesis …
regulates various biological processes, including proliferation, metastasis, angiogenesis …
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery
Many lead compounds fail to reach clinical trials despite being potent because of low
bioavailability attributed to their insufficient solubility making solubility a primary and crucial …
bioavailability attributed to their insufficient solubility making solubility a primary and crucial …
Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update
K Laxmikeshav, P Kumari… - Medicinal Research …, 2022 - Wiley Online Library
This review article proposes a comprehensive report of the design strategies engaged in the
development of various sulfur‐bearing cytotoxic agents. The outcomes of various studies …
development of various sulfur‐bearing cytotoxic agents. The outcomes of various studies …
[HTML][HTML] Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Cancer is one of the diseases with high morbidity and mortality on a global scale.
Chemotherapy remains the primary treatment option for most cancer patients, including …
Chemotherapy remains the primary treatment option for most cancer patients, including …
Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery
Currently, the development of anticancer drug resistance is significantly restricted the clinical
efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely …
efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely …
Discovery and development of natural product oridonin-inspired anticancer agents
Natural products have historically been, and continue to be, an invaluable source for the
discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in …
discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in …
Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection
Oridonin, a diterpenoid natural product commonly used in East Asian herbal medicine, is
garnering increased attention in the biomedical community due to its extensive biological …
garnering increased attention in the biomedical community due to its extensive biological …
Insights into drug discovery from natural products through structural modification
J Chen, W Li, H Yao, J Xu - Fitoterapia, 2015 - Elsevier
Natural products (NPs) have played a key role in drug discovery and are still a prolific
source of novel lead compounds or pharmacophores for medicinal chemistry …
source of novel lead compounds or pharmacophores for medicinal chemistry …
Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents
H Chen, Y Gao, A Wang, X Zhou, Y Zheng… - European journal of …, 2015 - Elsevier
Currently, there is a renewed interest in common dietaries and plant-based traditional
medicines for the prevention and treatment of cancer. In the search for potential anticancer …
medicines for the prevention and treatment of cancer. In the search for potential anticancer …
Discovery, X-ray crystallography, and anti-inflammatory activity of bromodomain-containing protein 4 (BRD4) BD1 inhibitors targeting a distinct new binding site
Bromodomain-containing protein 4 (BRD4) is an emerging epigenetic drug target for
intractable inflammatory disorders. The lack of highly selective inhibitors among BRD4 …
intractable inflammatory disorders. The lack of highly selective inhibitors among BRD4 …